Physician profile
Anuja K Antony
NPI 1528228277
$326,061.70
in general payments reported to CMS, 2019-2025
19 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $32K · 2021: $39K · 2022: $69K · 2023: $53K · 2024: $50K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $120K · Travel and Lodging: $13K · Honoraria: $8,788 · Food and Beverage: $5,448 · Entertainment: $70.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $119,746.63 |
| Travel and Lodging | $12,887.17 |
| Honoraria | $8,787.50 |
| Food and Beverage | $5,447.66 |
| Entertainment | $70.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137,633.20 | 2022-2025 | Natrelle Saline-Filled Breast Implants, Revolve, Alloderm |
| Allergan, INC. | $132,601.00 | 2019-2022 | |
| Stryker Corporation | $25,966.08 | 2019-2022 | |
| Davol INC. | $24,873.86 | 2021-2025 | Arista Ah Flexitip, Phasix Mesh |
| Merz North America, INC. | $2,704.92 | 2022-2025 | |
| Biom'Up France Sas | $1,000.00 | 2021 | |
| Sientra, INC. | $185.85 | 2022 | |
| Acera Surgical, INC. | $133.51 | 2024 | Restrata Wound Matrix |
| Rti Surgical, INC | $125.94 | 2023 | |
| Depuy Synthes Sales INC. | $125.69 | 2025 | Trumatch, Na |
| Becton, Dickinson and Company | $118.26 | 2021-2022 | |
| Galderma Laboratories, L.P. | $106.45 | 2019-2024 | Dysport |
| Revance Therapeutics, INC. | $102.55 | 2024-2025 | Daxxify |
| Kls-Martin L.P. | $101.99 | 2024 | |
| Medtronic, INC. | $91.13 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $70.13 | 2023 | |
| Motiva USA, LLC | $57.51 | 2025 | |
| Tela Bio, INC. | $40.73 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $22.90 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuja Antony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.